Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2026(Status and Outlook)
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths. The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
The global Neglected Tropical Diseases Drugs and Vaccine market size was estimated at USD 377.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neglected Tropical Diseases Drugs and Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neglected Tropical Diseases Drugs and Vaccine market.
Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Market Segmentation (by Type)
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neglected Tropical Diseases Drugs and Vaccine Market
Overview of the regional outlook of the Neglected Tropical Diseases Drugs and Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neglected Tropical Diseases Drugs and Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neglected Tropical Diseases Drugs and Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neglected Tropical Diseases Drugs and Vaccine market size was estimated at USD 377.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neglected Tropical Diseases Drugs and Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neglected Tropical Diseases Drugs and Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neglected Tropical Diseases Drugs and Vaccine market.
Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Market Segmentation (by Type)
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neglected Tropical Diseases Drugs and Vaccine Market
Overview of the regional outlook of the Neglected Tropical Diseases Drugs and Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neglected Tropical Diseases Drugs and Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neglected Tropical Diseases Drugs and Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.8.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neglected Tropical Diseases Drugs and Vaccine Market
5.7 ESG Ratings of Leading Companies
6 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2020-2025)
6.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2020-2025)
7 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2020-2025)
7.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
8 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SALES BY REGION
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
8.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.3 North America
8.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.5.2 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.6.2 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.7.2 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Neglected Tropical Diseases Drugs and Vaccine by Region(2020-2025)
9.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neglected Tropical Diseases Drugs and Vaccine Production
9.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neglected Tropical Diseases Drugs and Vaccine Production
9.5.1 Europe Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
9.6.1 Japan Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
9.7.1 China Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.7.2 China Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Artecef BV
10.1.1 Artecef BV Basic Information
10.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.1.4 Artecef BV Business Overview
10.1.5 Artecef BV SWOT Analysis
10.1.6 Artecef BV Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Basic Information
10.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.3.4 AstraZeneca Business Overview
10.3.5 AstraZeneca SWOT Analysis
10.3.6 AstraZeneca Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Sanofi-Aventis
10.5.1 Sanofi-Aventis Basic Information
10.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.5.4 Sanofi-Aventis Business Overview
10.5.5 Sanofi-Aventis Recent Developments
10.6 Ranbaxy Labs
10.6.1 Ranbaxy Labs Basic Information
10.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.6.4 Ranbaxy Labs Business Overview
10.6.5 Ranbaxy Labs Recent Developments
10.7 Lupin
10.7.1 Lupin Basic Information
10.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.7.4 Lupin Business Overview
10.7.5 Lupin Recent Developments
10.8 Macleods Pharmaceuticals
10.8.1 Macleods Pharmaceuticals Basic Information
10.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.8.4 Macleods Pharmaceuticals Business Overview
10.8.5 Macleods Pharmaceuticals Recent Developments
10.9 Cipla
10.9.1 Cipla Basic Information
10.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.9.4 Cipla Business Overview
10.9.5 Cipla Recent Developments
10.10 Romark Laboratories
10.10.1 Romark Laboratories Basic Information
10.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.10.4 Romark Laboratories Business Overview
10.10.5 Romark Laboratories Recent Developments
10.11 Toyama Chemica
10.11.1 Toyama Chemica Basic Information
10.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.11.4 Toyama Chemica Business Overview
10.11.5 Toyama Chemica Recent Developments
11 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET FORECAST BY REGION
11.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast
11.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
11.2.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Type (2026-2035)
12.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neglected Tropical Diseases Drugs and Vaccine by Type (2026-2035)
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.8.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neglected Tropical Diseases Drugs and Vaccine Market
5.7 ESG Ratings of Leading Companies
6 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2020-2025)
6.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2020-2025)
7 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2020-2025)
7.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
8 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SALES BY REGION
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
8.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.3 North America
8.3.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.3.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.4.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.5.2 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.6.2 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.7.2 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Neglected Tropical Diseases Drugs and Vaccine by Region(2020-2025)
9.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neglected Tropical Diseases Drugs and Vaccine Production
9.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neglected Tropical Diseases Drugs and Vaccine Production
9.5.1 Europe Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
9.6.1 Japan Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
9.7.1 China Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
9.7.2 China Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Artecef BV
10.1.1 Artecef BV Basic Information
10.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.1.4 Artecef BV Business Overview
10.1.5 Artecef BV SWOT Analysis
10.1.6 Artecef BV Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Basic Information
10.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.3.4 AstraZeneca Business Overview
10.3.5 AstraZeneca SWOT Analysis
10.3.6 AstraZeneca Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Sanofi-Aventis
10.5.1 Sanofi-Aventis Basic Information
10.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.5.4 Sanofi-Aventis Business Overview
10.5.5 Sanofi-Aventis Recent Developments
10.6 Ranbaxy Labs
10.6.1 Ranbaxy Labs Basic Information
10.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.6.4 Ranbaxy Labs Business Overview
10.6.5 Ranbaxy Labs Recent Developments
10.7 Lupin
10.7.1 Lupin Basic Information
10.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.7.4 Lupin Business Overview
10.7.5 Lupin Recent Developments
10.8 Macleods Pharmaceuticals
10.8.1 Macleods Pharmaceuticals Basic Information
10.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.8.4 Macleods Pharmaceuticals Business Overview
10.8.5 Macleods Pharmaceuticals Recent Developments
10.9 Cipla
10.9.1 Cipla Basic Information
10.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.9.4 Cipla Business Overview
10.9.5 Cipla Recent Developments
10.10 Romark Laboratories
10.10.1 Romark Laboratories Basic Information
10.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.10.4 Romark Laboratories Business Overview
10.10.5 Romark Laboratories Recent Developments
10.11 Toyama Chemica
10.11.1 Toyama Chemica Basic Information
10.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
10.11.4 Toyama Chemica Business Overview
10.11.5 Toyama Chemica Recent Developments
11 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET FORECAST BY REGION
11.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast
11.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
11.2.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Type (2026-2035)
12.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Neglected Tropical Diseases Drugs and Vaccine by Type (2026-2035)
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 5. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2025)
Table 11. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2020-2025)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2025)
Table 39. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025)
Table 44. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Artecef BV Basic Information
Table 63. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 64. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Artecef BV Business Overview
Table 66. Artecef BV SWOT Analysis
Table 67. Artecef BV Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 70. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. AstraZeneca Basic Information
Table 75. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 76. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca SWOT Analysis
Table 79. AstraZeneca Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 82. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Sanofi-Aventis Basic Information
Table 86. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 87. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sanofi-Aventis Business Overview
Table 89. Sanofi-Aventis Recent Developments
Table 90. Ranbaxy Labs Basic Information
Table 91. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 92. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ranbaxy Labs Business Overview
Table 94. Ranbaxy Labs Recent Developments
Table 95. Lupin Basic Information
Table 96. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 97. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lupin Business Overview
Table 99. Lupin Recent Developments
Table 100. Macleods Pharmaceuticals Basic Information
Table 101. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 102. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Macleods Pharmaceuticals Business Overview
Table 104. Macleods Pharmaceuticals Recent Developments
Table 105. Cipla Basic Information
Table 106. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 107. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Cipla Business Overview
Table 109. Cipla Recent Developments
Table 110. Romark Laboratories Basic Information
Table 111. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 112. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Romark Laboratories Business Overview
Table 114. Romark Laboratories Recent Developments
Table 115. Toyama Chemica Basic Information
Table 116. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 117. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Toyama Chemica Business Overview
Table 119. Toyama Chemica Recent Developments
Table 120. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Neglected Tropical Diseases Drugs and Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 5. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2025)
Table 11. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type (2020-2025)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
Table 35. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2025)
Table 39. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025)
Table 44. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Artecef BV Basic Information
Table 63. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 64. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Artecef BV Business Overview
Table 66. Artecef BV SWOT Analysis
Table 67. Artecef BV Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 70. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. AstraZeneca Basic Information
Table 75. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 76. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca SWOT Analysis
Table 79. AstraZeneca Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 82. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Sanofi-Aventis Basic Information
Table 86. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 87. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Sanofi-Aventis Business Overview
Table 89. Sanofi-Aventis Recent Developments
Table 90. Ranbaxy Labs Basic Information
Table 91. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 92. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ranbaxy Labs Business Overview
Table 94. Ranbaxy Labs Recent Developments
Table 95. Lupin Basic Information
Table 96. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 97. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lupin Business Overview
Table 99. Lupin Recent Developments
Table 100. Macleods Pharmaceuticals Basic Information
Table 101. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 102. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Macleods Pharmaceuticals Business Overview
Table 104. Macleods Pharmaceuticals Recent Developments
Table 105. Cipla Basic Information
Table 106. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 107. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Cipla Business Overview
Table 109. Cipla Recent Developments
Table 110. Romark Laboratories Basic Information
Table 111. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 112. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Romark Laboratories Business Overview
Table 114. Romark Laboratories Recent Developments
Table 115. Toyama Chemica Basic Information
Table 116. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 117. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Toyama Chemica Business Overview
Table 119. Toyama Chemica Recent Developments
Table 120. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Neglected Tropical Diseases Drugs and Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Market PEST Analysis
Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type
Figure 27. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2025
Figure 29. Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2025)
Figure 30. Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2025
Figure 35. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2025)
Figure 36. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2025
Figure 37. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025)
Figure 40. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 43. North America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 45. U.S. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 55. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region in 2024
Figure 68. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 80. South America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 82. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neglected Tropical Diseases Drugs and Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Market PEST Analysis
Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type
Figure 27. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2025
Figure 29. Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2025)
Figure 30. Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 33. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2025
Figure 35. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2025)
Figure 36. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2025
Figure 37. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2025)
Figure 40. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 43. North America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 45. U.S. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 55. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region in 2024
Figure 68. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Country in 2024
Figure 80. South America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country in 2024
Figure 82. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neglected Tropical Diseases Drugs and Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Neglected Tropical Diseases Drugs and Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Neglected Tropical Diseases Drugs and Vaccine Market Share Forecast by Application (2026-2035)
